108 related articles for article (PubMed ID: 6093434)
1. Studies on aging processes.
Agnati LF; Fuxe K; Benfenati F; Toffano G; Cimino M; Battistini N; Calza L; Merlo Pich E
Acta Physiol Scand Suppl; 1984; 532():45-61. PubMed ID: 6093434
[TBL] [Abstract][Full Text] [Related]
2. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons.
Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M
Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030
[TBL] [Abstract][Full Text] [Related]
3. Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects.
Agnati LF; Fuxe K; Benfenati F; Zini I; Zoli M; Fabbri L; Härfstrand A
Acta Physiol Scand Suppl; 1984; 532():5-36. PubMed ID: 6149667
[TBL] [Abstract][Full Text] [Related]
4. Brain enkephalin receptors in Parkinson's disease.
Rinne UK; Rinne JK; Rinne JO; Laakso K; Tenovuo O; Lönnberg P; Koskinen V
J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
[TBL] [Abstract][Full Text] [Related]
5. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
6. Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Synapse; 1998 Oct; 30(2):227-35. PubMed ID: 9723793
[TBL] [Abstract][Full Text] [Related]
7. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
9. Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography.
Trugman JM; Geary WA; Wooten GF
Nature; 1986 Sep 18-24; 323(6085):267-9. PubMed ID: 3762674
[TBL] [Abstract][Full Text] [Related]
10. Quantitative image analysis with densitometry for immunohistochemistry and autoradiography of receptor binding sites--methodological considerations.
Peretti-Renucci R; Feuerstein C; Manier M; Lorimier P; Savasta M; Thibault J; Mons N; Geffard M
J Neurosci Res; 1991 Apr; 28(4):583-600. PubMed ID: 1678436
[TBL] [Abstract][Full Text] [Related]
11. Brain neurotransmitters and neuropeptides in Parkinson's disease.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Lönnberg P
Acta Physiol Pharmacol Latinoam; 1984; 34(3):287-99. PubMed ID: 6099688
[TBL] [Abstract][Full Text] [Related]
12. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
[TBL] [Abstract][Full Text] [Related]
13. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
15. Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting.
Agnati LF; Fuxe K; Calza L; Benfenati F; Cavicchioli L; Toffano G; Goldstein M
Acta Physiol Scand; 1983 Dec; 119(4):347-63. PubMed ID: 6141701
[TBL] [Abstract][Full Text] [Related]
16. [3H]DPDPE binding to delta opioid receptors in the rat mesocorticolimbic and nigrostriatal pathways is transiently increased by acute ethanol administration.
Méndez M; Morales-Mulia M; Leriche M
Brain Res; 2004 Dec; 1028(2):180-90. PubMed ID: 15527743
[TBL] [Abstract][Full Text] [Related]
17. Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
Rinne UK; Rinne JO; Rinne JK; Laakso K; Laihinen A; Lönnberg P
J Neural Transm Suppl; 1983; 18():279-86. PubMed ID: 6308149
[TBL] [Abstract][Full Text] [Related]
18. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
19. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
20. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
